Simplex Trading’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Simplex Trading’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,700	Closed	-$125K	–	10305
2023 Q2	$125K	Buy	2,700 +800	+42%	+$27.7K	﹤0.01%	4820
2023 Q1	$54K	Sell	1,900 -2,400	-56%	-$71.1K	﹤0.01%	5844
2022 Q4	$134K	Sell	4,300 -48,200	-92%	-$1.57M	﹤0.01%	4730
2022 Q3	$1.06M	Buy	52,500 +49,800	+1,844%	+$907K	﹤0.01%	2573
2022 Q2	$41K	Buy	+2,700	New	+$46.4K	﹤0.01%	6751

Simplex Trading's DICE Position: Q3 2023 in Review

Simplex Trading sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 4,062 shares — an estimated $188K sold.

Simplex Trading first reported a position in DICE in Q1 2022 and held it in 5 quarters. The position peaked at $228K in Q1 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Simplex Trading reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Simplex Trading sold 4,062 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $188K.
Simplex Trading first reported a position in DICE Therapeutics, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Simplex Trading's DICE Therapeutics, Inc. Common Stock position peaked at $228K in Q1 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.